| Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 | Mar'18 | |
|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||
Net loss | ||||||
-9,065 | -7,428 | -8,353 | -5,575 | -6,501 | -6,634 | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation | ||||||
193 | 169 | 174 | 168 | 161 | 169 | |
Noncash interest expense | ||||||
176 | 185 | 189 | 166 | 157 | 127 | |
Change in assets and liabilities held at fair value (Note 5) | ||||||
-507 | -196 | 174 | 178 | -171 | -289 | |
Bad debt expense | ||||||
- | -21 | -15 | - | - | - | |
Share-based compensation | ||||||
2,712 | 1,093 | 1,250 | 225 | 131 | 406 | |
Other non-cash reconciling items | ||||||
- | - | - | -4 | 3 | -8 | |
Changes in assets and liabilities: | ||||||
Accounts receivable | ||||||
713 | 609 | 752 | 56 | 946 | 403 | |
Prepaid expenses and other current assets | ||||||
896 | -748 | 1,019 | -218 | 439 | -628 | |
Inventories | ||||||
-249 | 432 | 224 | 119 | -82 | 239 | |
Accounts payable and accrued expenses | ||||||
823 | 779 | 341 | 1,611 | -640 | 489 | |
Deferred revenue | ||||||
15 | 5 | -12 | -72 | 217 | 71 | |
Other non-current assets and liabilities | ||||||
-103 | -37 | -48 | 85 | 21 | -17 | |
Net cash used in operating activities | ||||||
-5,908 | -5,278 | -8,547 | -3,680 | -7,631 | -5,072 | |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||
Purchase of equipment and furniture | ||||||
182 | 91 | 80 | 114 | 20 | 122 | |
Net cash used in investing activities | ||||||
-182 | -91 | -80 | -114 | -20 | -122 | |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | ||||||
0 | 0 | 65,100 | - | - | - | |
Proceeds from the exercise of common stock options | ||||||
496 | 104 | 8 | 1 | 8 | 54 | |
Initial public offering costs | ||||||
- | - | 1,400 | - | - | - | |
Payment for asset purchase obligation | ||||||
- | 250 | 31 | - | 31 | 34 | |
Principal payments on capital lease obligation | ||||||
9 | 9 | 10 | 9 | 9 | 9 | |
Net cash provided by financing activities | ||||||
398 | -1,602 | 63,667 | -40 | 24,750 | 11 | |
Increase in cash, cash equivalents and restricted cash | ||||||
-5,692 | -6,971 | 55,040 | -3,834 | 17,099 | -5,183 | |
Cash paid for interest | ||||||
529 | 521 | 511 | 514 | 510 | 499 | |
Supplemental disclosure of non-cash investing and financing activities | ||||||
Conversion of convertible preferred stock to common stock | ||||||
0 | 0 | 68,423 | - | - | - | |
Conversion of convertible preferred stock warrants to common stock warrants | ||||||
0 | 0 | 1,835 | - | - | - | |
Offering costs included in accounts payable and accrued expenses | ||||||
- | - | 1,447 | - | - | - | |